Markets:

Overview

News

Currencies

International

Treasuries

Elicio Therapeutics, Inc. - Common Stock (NQ:ELTX)

9.155 -0.415 (-4.34%)

Streaming Delayed Price Updated: 3:36 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Elicio Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >

Elicio Therapeutics (NASDAQ:ELTX) Q1 2026 Results Show Extended Cash Runway Ahead of Key Phase 2 Data Readout ↗

May 11, 2026

Via Chartmill

Elicio (ELTX) Q2 Loss Beats Estimates ↗

August 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 21, 2025

Via Benzinga

First Patient Dosed In Phase 2 Study Of Elicio Therapeutics’ ELI-002 7P

February 01, 2024

--News Direct--

Via News Direct

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 23, 2025

Via Benzinga

Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket ↗

January 21, 2025

Via Benzinga

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket ↗

January 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 01, 2024

Via Benzinga

ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q2 2024 ↗

August 13, 2024

ELTX stock results show that Elicio Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday? ↗

June 28, 2024

Elicio Therapeutics announced promising preliminary data from the AMPLIFY-7P Phase 1a study of ELI-002 7P, showing extended median disease-free survival in patients with mKRAS-driven solid tumors.

Via Benzinga

Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today? ↗

June 28, 2024

Elicio Therapeutics stock is down on Friday after the company announced a proposed public offering for shares of ELTX this morning.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 28, 2024

Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower!

Via InvestorPlace

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

June 10, 2024

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

Via News Direct

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 16, 2024

Via Benzinga

ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q1 2024 ↗

May 15, 2024

ELTX stock results show that Elicio Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

April 11, 2024

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

Via News Direct

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 05, 2024

Via Benzinga

Unlocking the Power of Immunotherapy: Elicio Therapeutics’ (NASDAQ: ELTX) Novel AMP Platform

April 05, 2024

--News Direct--

Via News Direct

Topics Death

ELTX Stock Earnings: Elicio Therapeutics Misses EPS for Q4 2023 ↗

April 02, 2024

ELTX stock results show that Elicio Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Benzinga's 2024 Virtual Healthcare: What's Next In Health? ↗

March 19, 2024

The 2024 Benzinga Virtual Healthcare Summit brings together top healthcare professionals and companies to discuss industry trends, advancements in technology, and the future of healthcare. Don't miss...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 07, 2024

Via Benzinga

Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy

February 06, 2024

--News Direct--

Via News Direct

Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy ↗

February 05, 2024

A clinical-stage biotechnology company has published promising preclinical data in Cancer Immunology Research, a journal of the American Association for Cancer Research (AACR).

Via Benzinga

First Patient Dosed In Phase 2 Study Of Elicio Therapeutics' ELI-002 7P ↗

January 31, 2024

A phase 2 trial by a clinical-stage biotechnology company is kicking into full gear.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Delivering useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/pages/Cabling-Installation-and-Maintenance/298118662118

https://www.instagram.com/cim_magazine/

https://www.linkedin.com/company/3962332

http://twitter.com/CABLINGMAG

Affiliated Brands

DATA CENTER FRONTIER

ISE

LIGHTWAVE

DIGITAL INFRASTRUCTURE GROUP

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions